Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Squamous-Cell Lung Cancer × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 900 Lung Neoplasms 677 Small Cell Lung Carcinoma 141 Adenocarcinoma of Lung 64 Breast Neoplasms 63 Neoplasms 60 Stomach Neoplasms 39 Pleural Effusion, Malignant 39 NSCLC 39 Melanoma 39 Brain Neoplasms 39 Colorectal Neoplasms 37 Mesothelioma, Malignant 35 Pancreatic Neoplasms 34 Head and Neck Neoplasms 27 Ovarian Neoplasms 26 Neoplasm Metastasis 26 Mesothelioma 25 Prostatic Neoplasms 24 Esophageal Neoplasms 24 Colonic Neoplasms 21 Urinary Bladder Neoplasms 20 Thymoma 20 Carcinoma 19 Lung Diseases 17 Carcinoma, Hepatocellular 17 Thoracic Neoplasms 16 Pleural Effusion 16 Disease 16 Carcinoma, Renal Cell 16

Interventions

Platinum Compounds 1 Nivolumab 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03823625 2020-03-25

SQUINT

Fondazione Ricerca Traslazionale

Phase 2 Unknown

Squamous-Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡